Mr. Stewart has broad experience in the medical device and biopharmaceutical sector and has held positions as VP Research, VP Drug Development, Senior VP Operations and Chief Operating Officer. He has over 35 publications in peer-reviewed medical journals and is an inventor on several issued patents including IMB’s intellectual property.

Dr. Griffith has over twenty years experience in the biotechnology sector. He has extensive hands-on experience in creating, managing and leading highly productive and effective teams in product development, discovery research, preclinical toxicology, manufacturing, business development and product commercialization. He has held Executive positions in project management, business development and product development.

Mr. Laurin brings to IMB 15 years experience in the pharmaceutical, biotechnology and medical device industries, 10 of which have been spent in Business Development roles. His experience includes national and international product licensing, development and manufacturing agreements, as well as mergers, acquisitions and initial public offerings. Mr. Laurin has a BComm and M.Sc. degree from Concordia University in Montreal, Canada.